Clinical trial

Standard Comprehensive Intervention to Treat First-episode Schizophrenia

NCT01057849

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2008-09-01

PhaseNA

Study timeline

Study start (unknown)2008-09-01Date precision: month

Registry last updated2010-01-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

risperidoneDRUG · verified · RxNorm: risperidone

olanzapineDRUG · verified · RxNorm: olanzapine

AripiprazoleDRUG · verified · RxNorm: aripiprazole

Sponsors & collaborators

Peking Universitylead sponsor

Ministry of Science and Technology of the People´s Republic of Chinacollaborator

Mapped research locations

BeijingBeijing Municipality, China2 ShanghaiShanghai Municipality, China1 ChangshaHunan, China1 ChengduSichuan, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01057849 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.